BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

4521 related articles for article (PubMed ID: 6440898)

  • 41. 5-S-Cysteinyldopa and dopa in serum during treatment with 8-methoxypsoralen and UVA light.
    Hansson C; Rorsman H; Rosengren E; Tegner E
    Acta Derm Venereol; 1981; 61(3):251-5. PubMed ID: 6167110
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Liquid chromatographic method for monitoring therapeutic concentrations of L-dopa and dopamine in serum.
    Riggin RM; Alcorn RL; Kissinger PT
    Clin Chem; 1976 Jun; 22(6):782-4. PubMed ID: 1277462
    [TBL] [Abstract][Full Text] [Related]  

  • 43. 5-S-cysteinyldopa in the plasma of melanoma patients and the renal clearance of this amino acid.
    Agrup G; Andersson T; Falck B; Persson K; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1975; 55(1):5-6. PubMed ID: 46673
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Tyrosinase activity in the medium of human melanoma cell cultures.
    Jergil B; Lindbladh C; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(3):205-8. PubMed ID: 6192632
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [High-performance liquid chromatographic determination of urinary 5-S, 2-S-, 6-S-cysteinyldopa and 2,5-S,S-dicysteinyldopa (author's transl)].
    Morishima T; Saito M; Fujita M; Fukada E; Hanawa S
    Nihon Hifuka Gakkai Zasshi; 1982 Jan; 92(1):53-6. PubMed ID: 6804671
    [No Abstract]   [Full Text] [Related]  

  • 46. Determination of 5-S-cysteinyldopa in melanomas with a fluorimetric method.
    Rorsman H; Rosengren AM; Rosengren E
    Yale J Biol Med; 1973 Dec; 46(5):516-22. PubMed ID: 4779132
    [No Abstract]   [Full Text] [Related]  

  • 47. 5-S-cysteinyldopa and trichochromes in red feathers.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):269-70. PubMed ID: 78644
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Diastereomers of 5-S-cysteinyldopa.
    Agrup G; Edholm LE; Rorsman H; Rosengren E
    Acta Derm Venereol; 1983; 63(1):59-61. PubMed ID: 6191491
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quality control procedure for 6-[18F]fluoro-L-DOPA: a presynaptic PET imaging ligand for brain dopamine neurons.
    Chen JJ; Huang SJ; Finn RD; Kirk KL; Francis BE; Adams HR; Cohen RM; Chiueh CC
    J Nucl Med; 1989 Jul; 30(7):1249-56. PubMed ID: 2500503
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Determination of free DOPA and 3-O-methyl-DOPA in human plasma by high-performance liquid chromatography with electrochemical detection.
    Melzi d'Eril GV; Rizzo V
    J Chromatogr; 1991 Aug; 553(1-2):265-9. PubMed ID: 1787158
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Free and bound 5-S-cysteinyldopa and dopa in human malignant melanomas.
    Agrup G; Hansson C; Rorsman H; Rosengren AM; Rosengren E
    Acta Derm Venereol; 1978; 58(3):270-2. PubMed ID: 78645
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Abnormal 3,4-dihydroxyphenylalanine (dopa) concentrations in plasma and urine of patients with cystic fibrosis.
    Schöni MH; Türler K; Käser H; Kraemer R
    Eur J Clin Invest; 1990 Jun; 20(3):272-8. PubMed ID: 2114988
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Plasma 5-S-cysteinyldopa correlates with tumor size in melanoma-bearing mice.
    Hu F; Woodward WR; Peterson LL
    J Invest Dermatol; 1988 Feb; 90(2):149-51. PubMed ID: 3123557
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Fluorescence histochemical demonstration of dopa thioethers by condensation with gaseous formaldehyde.
    Agrup G; Björklund A; Falck B; Jacobsson S; Lindvall O; Rorsman H; Rosengren E
    Histochemistry; 1977 May; 52(2):179-86. PubMed ID: 873815
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Oxidation of tyrosine residues in proteins by tyrosinase. Formation of protein-bonded 3,4-dihydroxyphenylalanine and 5-S-cysteinyl-3,4-dihydroxyphenylalanine.
    Ito S; Kato T; Shinpo K; Fujita K
    Biochem J; 1984 Sep; 222(2):407-11. PubMed ID: 6433900
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Protein-bound dopa and 5-S-cysteinyldopa in non-melanogenic tissues.
    Ito S; Jimbow K; Kato T; Kiyota M; Fujita K
    Acta Derm Venereol; 1983; 63(6):463-7. PubMed ID: 6198833
    [TBL] [Abstract][Full Text] [Related]  

  • 57. The renal handling of dopamine originating from L-dopa and gamma-glutamyl-L-dopa.
    Pestana M; Soares-da-Silva P
    Br J Pharmacol; 1994 Jun; 112(2):417-22. PubMed ID: 8075859
    [TBL] [Abstract][Full Text] [Related]  

  • 58. A simple, reliable and rapid method for increasing the responsiveness of the glassy carbon electrode (GCE) for the analysis of biogenic amines by high performance liquid chromatography with electrochemical detection (LCEC).
    Anton AH
    Life Sci; 1984 Jul; 35(1):79-85. PubMed ID: 6429465
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Seasonal variation in urinary excretion of 5-S-cysteinyldopa in healthy Japanese.
    Ito S; Kato T; Fujita K
    Acta Derm Venereol; 1987; 67(2):163-5. PubMed ID: 2438883
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Plasma catecholamines in the chronically cannulated sheep fetus: predominance of L-dihydroxyphenylalanine.
    Ben-Jonathan N; Arbogast LA; Rhoades TA; Schillo KK; Pau KY; Jackson GL
    Endocrinology; 1983 Jul; 113(1):216-21. PubMed ID: 6407822
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 227.